Clinical Trial Update: Post Exposure Treatment With Doxycycline for the Prevention of Relapsing Fever [Phase 2, Phase 3]

View source ↗

Summary

Phase 2 and Phase 3 clinical trial results evaluate doxycycline as post-exposure prophylaxis to prevent relapsing fever after tick exposure. The studies have be…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing Fever

Drugs mentioned

• Doxycycline (Doxycycline)

Snippet

Sponsor: Medical Corps, Israel Defense Force | Conditions: Relapsing Fever, Tick-borne, Jarisch Herxheimer Reaction | Phase 2, Phase 3 | Status: COMPLETED